Clin2
NCT07042516Possibly a fitRecruiting

Study of asimadoline for hot flashes in women

Vasomotor Symptoms

Part of Women’s health & pregnancy clinical trials.

This study tests an investigational drug called asimadoline to see if it can reduce hot flashes and night sweats in women going through menopause. It may help women who have frequent, bothersome symptoms and are not currently using other treatments for them.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
40 years to 62 years
Study type
Interventional

Who can take part

  • You are a woman between 40 and 62 years old.
  • You are either in menopause or late perimenopause (your periods are becoming irregular or have stopped).
  • You have at least 40 moderate to severe hot flashes per week, for two weeks in a row.
  • You have not used hormone therapy, hormonal birth control, or other medications for hot flashes (like antidepressants or gabapentin) in the past 4 to 8 weeks.
  • You are generally healthy, with no serious medical conditions like uncontrolled high blood pressure, heart disease, or a history of certain mental health conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07112651Recruiting
New medication for hot flashes in perimenopausal women

This study tests whether a new medication (CL25216) can help reduce hot flashes and other menopause symptoms in women going through perimenopause. It is specifically for overweight women who are still having irregular periods.

Vijayawada
NCT07210229Not yet recruiting
Ashwagandha for menopause symptom relief

This study tests whether an ashwagandha extract can ease menopause symptoms like hot flashes, sleep, and mood. It uses three groups, one of which receives a placebo (no active ingredient) to compare effects.

Huntsville, Alabama
NCT07606664Not yet recruiting· Phase 3
Study of a hot flash medication and its effects on heart and brain health

This study tests a medication called fezolinetant to see if it helps with hot flashes and also looks at its effects on blood vessels and the brain. It is for women who are going through menopause and having frequent moderate to severe hot flashes.

Chicago, Illinois
NCT07033013Recruiting
Study of an oral supplement for menopause hot flashes

This study tests an oral product to see if it can help with menopause symptoms like hot flashes. It is for women aged 40–65 who still have a uterus and are not on hormone therapy.

San Francisco, California
NCT07829653Not yet recruiting· Phase 3
Hot flash relief for Indian women in menopause

This study tests a non-hormonal pill called fezolinetant to see if it reduces hot flashes in Indian women going through menopause. It may offer a new option for women who cannot or prefer not to use hormone therapy.

NCT07254429Recruiting· Phase 2
The Copenhagen Menopause Study for hot flash relief

This study tests a new treatment for women going through menopause who have frequent hot flashes. It aims to find a safe and effective way to reduce moderate to severe hot flashes.

Herlev

Hear when a new Vasomotor Symptoms trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.